Petra H H van den Broek

Suggest Changes

Writes About:

Learn More
Cannabinoid type 1 (CB1) receptor antagonists have been developed for the treatment of obesity, but a major disadvantage is that they cause unwanted psychiatric effects. Selective targeting of(More)
  • 1